We propose that loss-of-function mutations of TLR9 may disrupt a peripheral-central immune crosstalk that is required for dampening inflammation and promoting clearance of toxic protein species, and consequentially contribute to the build-up of neuroinflammation and Aβ aggregates in AD development. This evidence concerns the gene TLR9 and Alzheimer disease.